Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity
β Scribed by D. Przepiorka; M. Dimopoulos; T. Smith; C. Ippoliti; K. Diener; M. Luna; R. E. Champlin
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 578 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We treated 73 patients with hematologic malignancies in first complete remission (acute lymphoblastic leukemia = 23 patients; acute non-lymphoblastic leukemia = 25 patients; chronic myelogenous leukemia in first chronic phase = 20 patients, and high grade lymphoma = five patients) with a uniform pre
## Abstract Twenty children with acute leukemia between 3 and 19 years of age underwent allogeneic bone marrow transplantation from HLAβmatched sibling donors after conditioning with totalβbody irradiation (1,200 cGy in six fractions of 200 cGy twice daily for 3 days) and high dose cytosine arabino